borderColor | #00Acc8 |
---|---|
titleColor | white |
borderWidth | 1 |
titleBGColor | #00Acc8 |
title | WMDA INFORMATION |
special | @anonymous |
---|---|
match | all |
Coronavirus (2019-nCoV)
A novel coronavirus (currently named 2019-nCoV) emerged in Wuhan, China in December 2019. WHO declared a global health emergency on 30 January 2020, and a number of blood and tissue donor guidelines have been issued - largely based on previous guidelines for SARS-CoV and MERS-CoV. Like SARS and MERS, 2019-nCoV displayed high mortality but low infectivity in the early weeks, with limited person-to-person transmission.
However, the epidemic quickly changed to display lower mortality but higher infectivity with increasing evidence of sustained person-to-person transmission. Various public health measures taken at a local or national level are likely to aid and/or complicate donor assessment, while the rapid evolution of the epidemic demands a precautionary yet flexible approach to suitability guidelines.
Read more here:
- Coronavirus - 2019-nCoV recommendation from donor suitability committee
- Information from registries whose operations are impacted by Coronavirus